0000950123-17-008099.txt : 20170815
0000950123-17-008099.hdr.sgml : 20170815
20170815172400
ACCESSION NUMBER: 0000950123-17-008099
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170630
FILED AS OF DATE: 20170815
DATE AS OF CHANGE: 20170815
EFFECTIVENESS DATE: 20170815
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pharmstandard International S.A.
CENTRAL INDEX KEY: 0001598762
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17790
FILM NUMBER: 171034677
BUSINESS ADDRESS:
STREET 1: 10A, RUE HENRI SCHNADT
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2530
BUSINESS PHONE: 352 24840131
MAIL ADDRESS:
STREET 1: 10A, RUE HENRI SCHNADT
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2530
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001598762
XXXXXXXX
06-30-2017
06-30-2017
Pharmstandard International S.A.
10A, RUE HENRI SCHNADT
LUXEMBOURG
N4
L-2530
13F HOLDINGS REPORT
028-17790
N
Eriks Martinovskis
Director
352 24840131
/s/ Eriks Martinovskis
Luxembourg
N4
08-15-2017
1
5
28842
false
1
Joint Stock Co Pharmstandard
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Argos Therapeutics Inc.
Common
040221103
4808
13242279
SH
DFND
1
0
13242279
0
Argos Therapeutics Inc.
Common
040221103
1859
5120604
SH
Call
DFND
1
0
5120604
0
Proteon Therapeutics Inc.
Common
74371L109
1777
1165344
SH
DFND
1
0
1165344
0
Protagonist Therapeutic, Inc.
Common
74366E102
11109
982270
SH
DFND
1
0
982270
0
Jounce Therapeutics
Common
481116101
9289
662063
SH
DFND
1
0
662063
0